STAAR Surgical CompanySTAANASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

businesswire.com

STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the “Board”) has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers, effective February 1, 2026. Mr. Foust and Ms. Andrews will work t.

defenseworld.net

Head-To-Head Contrast: Pro-Dex (NASDAQ:PDEX) vs. STAAR Surgical (NASDAQ:STAA)

Pro-Dex (NASDAQ: PDEX - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Profitability This table compares Pro-Dex and STAAR Surgical's

defenseworld.net

Analyzing Lancer Orthodontics (OTCMKTS:LANZ) and STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ: STAA - Get Free Report) and Lancer Orthodontics (OTCMKTS:LANZ - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk. Analyst Ratings This is a summary of recent

247wallst.com

Here Are Friday’s Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More

Pre-Market Stock Futures: The futures are trading higher as we get set to close out the week on a possible winning note, after a massive bounce-back rally on Thursday that saw all the major indices surge higher. The combination of a stiff 2-day sell-off, positive economic data showing inflation steady and trending lower this week,... Here Are Friday's Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More.

benzinga.com

STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence

STAAR Surgical Company (NASDAQ: STAA) shares are down on Thursday as the company is undergoing significant board changes.

businesswire.com

STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners, L.P. and its affiliates (“Broadwood”), which together own 31% of STAAR's outstanding common stock, today announced that Neal C. Bradsher and Richard T. LeBuhn of Broadwood and Christopher Wang of Yunqi Capital, which with its affiliates owns 6.5% of ST.

defenseworld.net

Broadwood Partners, L.P. Purchases 66,467 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Company (NASDAQ: STAA - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 66,467 shares of the stock in a transaction dated Wednesday, January 7th. The stock was bought at an average price of $22.00 per share, with a total value of $1,462,274.00. Following the purchase, the insider directly owned 15,422,904 shares in the

gurufocus.com

Market Today: Meta taps nuclear; GM books $6B EV charge

Stock News California billionaire tax splits tech leaders: Nvidia (NVDA) CEO Jensen Huang said he's âfineâ with a proposed one-time 5% California wealth tax

businesswire.com

Alcon Terminates Agreement to Acquire STAAR Surgical

GENEVA--(BUSINESS WIRE)--Alcon Terminates Agreement to Acquire STAAR Surgical.

benzinga.com

STAAR Surgical Merger With Alcon Fails After Shareholders Vote No

STAAR Surgical Company (NASDAQ: STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE: ALC) at the Special Meeting of Stockholders.

businesswire.com

Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), commented on the results of the Special Meeting of Shareholders (the “Special Meeting”) that was held earlier today in connection with the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC). Based on preliminary results, shareholders voted decisively to reject the.

businesswire.com

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on preliminary estimates by STAAR's proxy solicitor, STAAR did not receive the necessary stockholder votes to approve the merger agreement with Alcon at the Special Meeting of Stockholders held today. STAAR intends to terminate its merger agreement with Alcon. No terminat.

fool.com

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82%

Dallas-based Slotnik Capital acquired 635,000 shares of STAAR Surgical, adding an estimated $17.06 million position. The transaction resulted in a position representing 5.33% of Slotnik Capital's 13F AUM.

defenseworld.net

Analyzing STAAR Surgical (NASDAQ:STAA) and Lancer Orthodontics (OTCMKTS:LANZ)

Lancer Orthodontics (OTCMKTS:LANZ - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Profitability This table compares Lancer Orthodontics and STAAR

fool.com

What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag

London-based Sand Grove Capital Management acquired 829,123 shares of STAAR Surgical Company in the third quarter. The position was worth about $22.28 million at quarter-end.

defenseworld.net

STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of “Reduce” by Brokerages

STAAR Surgical Company (NASDAQ: STAA - Get Free Report) has been given a consensus rating of "Reduce" by the eleven analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and ten have assigned a hold recommendation to the company. The average 1 year price

businesswire.com

Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today responded to the fourth postponement of STAAR's Special Meeting of Shareholders (the “Special Meeting”) in connection with the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC). The Special Meeting, which was originally scheduled to be held on October 23, 2.

businesswire.com

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR to adjourn its Special Meeting of Stockholders in connection with the Alcon merger agreement (the “Special Meeting”). As a result, the Special Meeting, which was scheduled for December 19, 2025 at 8:30 a.m. Pacific Time, has been adjourned to Janua.

prnewswire.com

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal CHARLOTTE, N.C. , Dec. 17, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement reiterating its intention to vote AGAINST the Company's proposed sale to Alcon Inc. ("Alcon") (NYSE: ALC) and expressing its disappointment in the Company's Board of Directors' (the "Board") continued pursuit of the deal: As shareholders of STAAR Surgical for the past decade, we remain convicted in the long-term potential of the Company and are disappointed that the Board has continued to pursue the ill-advised sale to Alcon, which we do not believe is in the best interests of STAAR shareholders and does not represent adequate value for the Company.

businesswire.com

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR's outstanding common stock, continues to urge its fellow shareholders to vote “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC). Shareholders can find additional information at www.LetSTAARS.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance